Efficacy of IVIG plus Rituximab Desensitization Therapy on HLA Antibodies is Independent of HLA Loci.

被引：0
|
作者：
Zhang, X. [1 ]
Jordan, S. [2 ]
机构：
[1] Cedars Sinai Hlth Syst, Comprehens Transplant Ctr, HLA & Immunogenet Lab, Los Angeles, CA USA
[2] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A146
引用
收藏
页码：524 / 525
页数：2
相关论文
共 50 条
  • [1] HLA Desensitization in Pediatric Heart Transplant Candidates: Efficacy of Rituximab and IVIg
    Schumacher, K. R.
    Schauss, D.
    Schall, C. A.
    Kamoun, M.
    Ramon, D.
    Zamberlan, M. C. G.
    Gajarski, R. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S168 - S168
  • [2] HLA desensitization in pediatric heart transplant candidates: Efficacy of rituximab and IVIg
    Schumacher, Kurt R.
    Ramon, Daniel S.
    Kamoun, Malek
    Caruthers, Regine
    Gajarski, Robert J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (09): : 1041 - 1042
  • [3] IVIG plus single-dose rituximab is an effective desensitization strategy for highly-HLA sensitized patients
    Vo, Ashley A.
    Cao, Kai
    Lai, Chih-Hung
    Reinsmoen, Nancy
    Toyoda, Mieko
    Ge, Shili
    Peng, Alice
    Villicana, Rafael
    Kahwaji, Joseph
    Jordan, Stanley C.
    XENOTRANSPLANTATION, 2009, 16 (05) : 333 - 333
  • [4] Efficacy and Cost Analysis of Desensitization Using IVIG and Rituximab for Transplanting Broadly HLA-Sensitized (HS) Patients
    Vo, A. A.
    Kahwaji, J.
    Peng, A.
    Villicana, R.
    Jordan, S. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 91 - 91
  • [5] Use of IVIG plus single dose rituximab for desensitization of highly-HLA sensitized patients awaiting kidney transplantation
    Vo, Ashley A.
    Chang, Robert
    Toyoda, Mieko
    Reinsmoen, Nancy
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 181 - 181
  • [6] Desensitization of highly HLA sensitized crossmatch (+) patients awaiting living donor (LD) kidney transplantation using IVIG plus Rituximab
    Vo, Ashley A.
    Chang, Robert
    Toyoda, Mieko
    Reinsmoen, Nancy
    Lukovsky, Marina
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 353 - 353
  • [7] Analysis of Factors Associated with Unresponsiveness to Desensitization Using IVIG and Rituximab in Broadly HLA Sensitized Patients
    Vo, A. A.
    Choi, J.
    Kahwaji, J.
    Cisneros, K.
    Peng, A.
    Villicana, R.
    Reinsmoen, N.
    Lai, C. H.
    Cao, K.
    Jordan, S. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 233 - 234
  • [8] IVIG plus Rituximab as Desensitization Agents to Reduce Donor Specific Antibodies and Improve Transplant Rates in Highly Hla Sensitized (HS) Awaiting Deceased Donor Kidney Transplantation
    Najjar, R.
    Huang, E.
    Vo, A.
    Cho, J.
    Louis, S.
    Hang, A.
    Peng, A.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 537 - 537
  • [9] Comparison of Induction Therapy with Campath 1H vs Zenapax® in Highly-HLA Sensitized Patients (HS) Transplanted after Desensitization with IVIG plus Rituximab
    Vo, Ashley A.
    Lee, Roland
    Lin, Jennifer
    Kahwaji, Joseph
    Toyoda, Mieko
    Ge, Shili
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 317 - 317
  • [10] LOW EFFICACY OF IVIG/RITUXIMAB IN DESENSITIZING EXTREMELY HLA-SENSITIZED PATIENTS.
    Warner, Paul
    Nelson, Karen
    Florence, Lisa
    HUMAN IMMUNOLOGY, 2010, 71 : S71 - S71
12345